Salvecin Uses, Dosage, Side Effects and more
Salvecin is a fully-human monoclonal antibody (IgG1λ) targeting the Staphylococcus aureus alpha-toxin or the S. aureus alpha-hemolysin and thereby preserving human immune cells by protecting against destruction of host cells mediated by the toxin.
| Attribute | Details |
|---|---|
| Trade Name | Salvecin |
| Generic | Tosatoxumab |
| Tosatoxumab Other Names | Tosatoxumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Salvecin works
Staphylococcus aureus alpha-toxin is a virulence factor secreted by methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA), with S. aureus being a leading cause of hospital-acquired lower respiratory tract infections and bloodstream, skin, soft tissue, and surgical site infections. Salvecin acts as a monoclonal antibody against infections caused by MRSA and MSSA by targeting the S. aureus alpha-toxin, with its mode of action being independent of the antibiotic resistance profile of S. aureus.
